Vaxart Inc (NASDAQ: VXRT)
$0.67
+0.0033 ( +0.49% ) 1.8M
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Market Data
Open
$0.67
Previous close
$0.67
Volume
1.8M
Market cap
$120.03M
Day range
$0.66 - $0.72
52 week range
$0.52 - $1.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 75 | May 13, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
def | Proxies and info statements | 5 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
pre | Proxies and info statements | 5 | Apr 18, 2024 |
4 | Insider transactions | 1 | Apr 01, 2024 |